


1. Nafarelin Acetate Hydrate (jan)
2. Synarel (tn)
3. Chebi:7446
4. Bcp19032
5. Ft-0642036
6. D00990
7. Rs 94991 298;rs-94991-298;rs94991298
| Molecular Weight | 1400.5 g/mol |
|---|---|
| Molecular Formula | C68H89N17O16 |
| Hydrogen Bond Donor Count | 18 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 33 |
| Exact Mass | 1399.66731982 g/mol |
| Monoisotopic Mass | 1399.66731982 g/mol |
| Topological Polar Surface Area | 513 Ų |
| Heavy Atom Count | 101 |
| Formal Charge | 0 |
| Complexity | 2760 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 9 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Synarel |
| PubMed Health | Nafarelin (Into the nose) |
| Drug Classes | Endocrine-Metabolic Agent |
| Drug Label | SYNAREL (nafarelin acetate) Nasal Solution is intended for administration as a spray to the nasal mucosa. Nafarelin acetate, the active component of SYNAREL Nasal Solution, is a decapeptide with the chemical name: 5-oxo-L-prolyl-L-histidyl-L-tryptoph... |
| Active Ingredient | Nafarelin acetate |
| Dosage Form | Spray, metered |
| Route | Nasal |
| Strength | eq 0.2mg base/spray |
| Market Status | Prescription |
| Company | Gd Searle |
| 2 of 2 | |
|---|---|
| Drug Name | Synarel |
| PubMed Health | Nafarelin (Into the nose) |
| Drug Classes | Endocrine-Metabolic Agent |
| Drug Label | SYNAREL (nafarelin acetate) Nasal Solution is intended for administration as a spray to the nasal mucosa. Nafarelin acetate, the active component of SYNAREL Nasal Solution, is a decapeptide with the chemical name: 5-oxo-L-prolyl-L-histidyl-L-tryptoph... |
| Active Ingredient | Nafarelin acetate |
| Dosage Form | Spray, metered |
| Route | Nasal |
| Strength | eq 0.2mg base/spray |
| Market Status | Prescription |
| Company | Gd Searle |